| Literature DB >> 8998971 |
P Peyon1, S Baloche, E Burzawa-Gerard.
Abstract
Previous in vivo experiments have indicated a potentiating role of growth hormone (GH) during experimentally induced vitellogenesis by 17-beta-estradiol (E2) in the female silver eel (Anguilla anguilla L.). To investigate whether GH has direct hepatic actions, the effects of hypophysial-purified and recombinant QH on vitellogenin (Vg) synthesis in response to E2 were tested on primary cultures of hepatocytes. Hepatocytes were prepared from control or E2-primed eels. Addition of E2 alone into the culture medium induced both Vg synthesis and secretion in a dose- and time-related fashion. Bovine growth hormone (bGH) alone had no effect on the induction of Vg synthesis or secretion. Bovine GH enhanced the in vitro effects of F2 on both Vg synthesis and secretion, an effect attenuated by an in vivo E2 priming which was dose-dependent with an ED(50) of 5 ng/ml. To investigate the specificity of GH action, purified eel and salmon GH and salmon, trout, and tilapia prolactins (PRL), as well as recombinant trout and tilapia GH, were tested, and the responses were compared to bGH. Purified salmon and homologous eel GH potentiated the vitellogenic response to F2. Recombinant GH were highly efficacious, excluding the presence of active contaminants in the potentiating effect of GH preparations. The potentiating effect of recombinant trout GH on the vitellogenic response was reduced at high doses (above 20 ng/ml), suggesting a down-regulation of GH binding sites by GH itself. Salmon PRL has minimal activity, but not trout and tilapia PRL, indicating that PRL is not an important potentiating factor on Vg synthesis in our model. It is concluded that GH acts directly on the liver to potentiate E2 induction of eel hepatic Vg synthesis. The potentiating effect of GH appears to be time- and dose-dependent and modulated as a function of hormonal status (E2 priming) of the eel.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8998971 DOI: 10.1006/gcen.1996.0068
Source DB: PubMed Journal: Gen Comp Endocrinol ISSN: 0016-6480 Impact factor: 2.822